Publications by authors named "Garry Forgeson"

Claim this Profile
H
High-dose chemotherapy for relapsed germ cell tumours: outcomes in low-volume specialized centres.
Elizabeth A Connolly, Andrew Weickhardt, Peter Grimison, Rebecca Asher, Gillian Z Heller, Garry Forgeson

BJU Int· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective audit on the use of prophylactic antiemetics and rates of CINV in patients receiving carboplatin AUC≥4 or combination anthracycline-cyclophosphamide.
Edward Lo, Malcolm Anderson, Rebecca Carroll, Garry Forgeson, Richard Isaacs

N Z Med J· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant chemotherapy in non-metastatic breast cancer: a study on practice trends in a regional cancer treatment service.
Edmond Ang, Navin Wewala, Rebecca Carroll, Garry Forgeson, Malcolm Anderson

Intern Med J· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus and zoledronic acid in patients with renal cell carcinoma with bone metastases: a randomized first-line phase II trial.
Reuben J Broom, Victoria Hinder, Katrina Sharples, Janie Proctor, Steven Duffey, Garry Forgeson

Clin Genitourin Cancer· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bleeding from gastrointestinal tract recurrence of non-seminomatous germ cell tumour testis, showing temporary response to gemcitabine and oxaliplatin chemotherapy.
Stephanie K Prince, Garry Forgeson

N Z Med J· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A workforce survey of New Zealand medical oncologists.
Simon Bidwell, Andrew Simpson, Richard Sullivan, Bridget Robinson, Wendy Thomas, Garry Forgeson

N Z Med J· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study.
Niall C Tebbutt, Kate Wilson, Val J Gebski, Michelle M Cummins, Diana Zannino, Garry Forgeson

J Clin Oncol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seek and ye shall find: Hodgkin's lymphoma presenting as paraneoplastic cerebellar degeneration.
Jeanne Tie, Garry Forgeson, Andrew McNabb, Justin Roebert

N Z Med J· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre.
Kathryn Chrystal, Simon Allan, Garry Forgeson, Richard Isaacs

N Z Med J· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis